WHO ICTRP trial
A double-blind, randomised, controlled multicentre trial of three misoprostol…
ISRCTN81170837 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN81170837 |
|---|---|
| Public title | A double-blind, randomised, controlled multicentre trial of three misoprostol regimens after pretreatment with mifepristone for termination of early pregnancy |
| Primary sponsor | UNDP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction (HRP) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | China;Finland;Hong Kong;Hungary;India;Mongolia;Norway;Romania;Singapore;Slovenia;Sweden;Viet Nam |
| Conditions | Induced abortion Pregnancy and Childbirth Abortion |
| Interventions | All women treated with a single dose of 200 mg mifepristone on Day 1. Day 3: Group A: 0.8 mg misoprostol orally and placebo tablets vaginally. Groups B and C: 0.8 mg misoprostol vaginally and placebo tablets orally. Groups A and B will… |
| Registration date | Jan 4, 2004 |
| Target size | 2100 |
| Secondary IDs | WHO/HRP ID 97903 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: